- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01906021
Study of New Software Used During Ablations
Prospective Pilot Observational Study Examining Cone Beam CT and CT Thermometry During Ablations
Background:
- Ablation is a procedure that heats tumor tissue to a high temperature to destroy it. Doctors perform this procedure by putting a probe in the tumor. This delivers heat to the site. Currently, doctors tell what area is heated by using the probe s manufacturer estimates. These estimates are imprecise. Doctors insert small needles to measure the temperature around the area being heated. Doctors also perform scans of the area, but these cannot show which tissue has been heated and which has not. Right now, only contrast scans can show that. But researchers have developed software that uses images from routine scans to create a temperature map. They want to test the software to see if doctors can monitor the procedure without using more needles and without contrast scans.
Objectives:
- To test software that might help doctors perform ablations better in the future.
Eligibility:
- People over 18 years of age already scheduled to have an ablation.
Design:
- Participants will be screened with a medical history.
- Participants will visit the clinic for their already-scheduled ablation. The doctor will use the study software to
analyze the temperature in the area being heated. The software will not come into contact with a participant s body.
- Participants will undergo scans that are necessary for the procedure, but one or two additional scans may be done as part of this study.
Study Overview
Status
Intervention / Treatment
Detailed Description
Background:
- Lack of reliable non-invasive method to monitor ablation zone during radiofrequency or microwave ablation
- Development of a non-invasive technique to examine temperature changes based on changes in CT or CBCT attenuation
Objectives:
-To measure accuracy of temperature monitoring using non-invasive thermomap (temperature imaging profile) method compared to the currently accepted invasive thermocouples method.
Eligibility:
Subjects are eligible if:
--They are scheduled in interventional radiology for hepatic radiofrequency or microwave ablation requiring thermocouples for monitoring
Subjects are excluded if they have:
- An altered mental status precluding understanding or consenting for the procedure
- A gross body weight exceeding 375 pounds (upper limit of angio table)
- A pregnancy
Design:
- Number of participants: 16
- Number of sites: 1
- Recruitment time frame: 2 years
- Type of study: pilot study to validate an image analysis thermometry technique
- Patients undergoing clinically indicated hepatic ablations are eligible for this protocol. As part of this study, one to two additional research scans of the liver may be acquired during the ablation and analyzed separately with our software and compared with thermocouple measurements. There will be no changes in devices, probes or additional probe manipulations as part of this study. The operator will not modify the procedure based on results of this software.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- INCLUSION CRITERIA:
- Subjects must be scheduled for a hepatic radiofrequency or microwave ablation in interventional radiology requiring thermocouples for temperature monitoring. Any patient undergoing a hepatic radiofrequency or microwave ablation could be eligible for this protocol.
- Must be age 18 years or older.
EXCLUSION CRITERIA:
- Subjects have an altered mental status precluding understanding or consenting to the procedure
- Subjects have a body weight in excess of 375 lbs.
- Subject is pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Intra-patient comparison of temperature map obtained during CT/CBCT with standard ablation temperature measurements
|
The study consists of acquiring one or maximum two additional CT or CBCT of the liver during hepatic RFA or MWA and analyzing the images to obtain a temperature map
Temperature measured with thermocouples (current clinically approved method consisting of invasive needle placement for point measurement in area of concern)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To measure accuracy of temperature monitoring using non-invasive thermomap (temperature imaging profile) method compared to the currently accepted invasive thermocouples method
Time Frame: two years
|
Bayesian median estimate will be used.
|
two years
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Cho YK, Rhim H, Noh S. Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol. 2011 Sep;26(9):1354-60. doi: 10.1111/j.1440-1746.2011.06812.x.
- Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001 Oct;177(4):777-82. doi: 10.2214/ajr.177.4.1770777.
- Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2008 Jun;66(3):200-7. doi: 10.1016/j.critrevonc.2008.01.003. Epub 2008 Mar 4.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 130178
- 13-CC-0178
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Cancer
-
Slawa CwajnaNova Scotia Health AuthorityWithdrawnPrimary Liver Cancer | Metastatic Liver CancerCanada
-
Duke UniversityCompletedPrimary Liver Cancer | Metastatic Liver Cancer From Any Cancer SiteUnited States
-
Célia TurcoCompletedPrimary Liver Cancer | Liver Metastases | Secondary Liver CancerFrance
-
University of CincinnatiActive, not recruitingLiver Metastases | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver CancerUnited States
-
Lisa H. Butterfield, Ph.D.National Cancer Institute (NCI)TerminatedHepatocellular Carcinoma | Liver Cancer | Cancer of Liver | Hepatoma | Hepatocellular Cancer | Hepatic Cancer | Liver Cell Carcinoma | Cancer, Hepatocellular | Liver Cancer, Adult | Liver Cell Carcinoma, Adult | Cancer of the Liver | Neoplasms, Liver | Hepatic Neoplasms | Neoplasms, HepaticUnited States
-
Radboud University Medical CenterTerumo Medical CorporationCompletedPrimary Liver Cancer | Liver Cancer | Liver Metastasis Colon CancerNetherlands
-
Tianjin Medical University Cancer Institute and...RecruitingPrimary Liver CancerChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
CNBG-Virogin Biotech (Shanghai) Ltd.Unknown
-
Shanghai Huihe Medical Technology Co., LtdEnrolling by invitation
Clinical Trials on CT/CBCT thermometry method
-
University of Michigan Rogel Cancer CenterCompleted
-
Emory UniversityNational Institutes of Health (NIH)Completed
-
Tanta UniversityCompleted
-
Philips Clinical & Medical Affairs GlobalRecruitingStroke, AcuteFrance, Brazil, Belgium, Spain, United States, Germany, Argentina, Netherlands, Romania, Turkey (Türkiye)
-
Istituto Ortopedico RizzoliCompletedPatellofemoral DislocationItaly
-
University of Wisconsin, MadisonNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Withdrawn
-
The First Hospital of QinhuangdaoCompletedTherapeutic Procedural ComplicationChina
-
University of AberdeenKing's College London; Zarqa UniversityRecruitingImpacted Third Molar Tooth | Inferior Alveolar Nerve InjuriesUnited Kingdom
-
FLUIDDA nvCompletedInfluence of Mouthpiece Design on Upper Airway GeometryBelgium
-
Luo YapingPeking Union Medical College HospitalNot yet recruitingGlomerular Filtration Rate | Positron-Emission Tomography(PET) | Kidney Neoplasms / SurgeryChina